CognitMarket market news, portfolio research, and investor insights

A new executive order from the Trump Administration aims to reduce homebuyer closing costs, potentially saving borrowers thousands. Key provisions include:

• Mortgage Insurance Pilot: Establishes a program for automatic cancellation of mortgage insurance for Fannie Mae and Freddie Mac loans once 80% LTV is reached, potentially saving hundreds monthly.
• Title Insurance: Targets lenders' title insurance for low-risk refinancing loans.
• Manufactured Homes: Creates a task force to streamline construction and lower costs for manufactured homes.

The order primarily impacts new home loans backed by Fannie Mae and Freddie Mac, aiming to ease financial burdens for those with less than 20% down payments [1].

Anthropic's S-1 filing has unveiled massive AI compute commitments, signaling sustained, high-intensity demand for chip and cloud providers [1] [2].

Key figures:

• Over $200 billion in NVIDIA-based compute commitments through 2034 [1].
• $161.2 billion in Broadcom TPU equipment leases [1].
• Over $110 billion each with Google and Amazon for cloud services [1].
• $44.9 billion with Microsoft [1].
• AMD's Helios deployment with MI450 GPUs expected to exceed $20 billion [1].

This unprecedented spending underscores the ongoing AI infrastructure build-out, driving renewed optimism in the sector [2].

Merck (MRK) announced significant positive Phase 3 trial results for two distinct endometrial cancer treatments, signaling strong pipeline momentum and potential market expansion [1] [2].

• Sacituzumab Tirumotecan (sac-TMT): Investigational TROP2-directed ADC reduced death risk by 32% and disease progression/death risk by 41% vs. chemotherapy in advanced/recurrent patients. FDA has accepted for priority review [1].
• Keytruda (pembrolizumab): Monotherapy reduced disease progression/death risk by 43% vs. chemotherapy in dMMR advanced/recurrent patients. Favorable OS trend observed [2].

These clinical wins underscore Merck's leadership in oncology and could drive substantial revenue growth in the coming years.

SpaceX has finalized a binding $40 billion master finance lease agreement with Apollo Global Management to acquire NVIDIA Vera Rubin chips, marking the largest committed GPU financing to date [1]. This massive deal aims to build the world's largest compute infrastructure, powering Grok and cloud services, with payback periods currently under one year due to surging demand [1].

This development underscores several key market trends:

• Intense AI Infrastructure Buildout: Companies are committing significant capital to secure GPU capacity [1] [2].
• Diversified Funding: Large-scale financing deals are emerging to support this growth, involving major financial players like Apollo, Goldman Sachs, BlackRock, and KKR [1] [3].
• AI Sector Dynamics: While some AI stocks rallied on Anthropic's IPO news [4], concerns about debt-fueled spending and potential overvaluation persist [5] [6]. Microsoft is also offering buyouts to 60,000 workers to reshape its workforce amid AI investments [7].

This record lease highlights the ongoing, aggressive expansion in AI compute infrastructure, even as market participants debate the sustainability and funding models for the broader AI boom.

KeyBanc maintains Overweight ratings on Monolithic Power Systems (MPWR) and Intel (INTC), raising price targets and expecting strong Q3 results with raised guidance for both.

Monolithic Power (MPWR):

• Price target raised to $2,100 [1].
• Expected to benefit from continued strength in Enterprise Data, server CPU, and AI demand, particularly with Nvidia's Vera Rubin ramp [1].
• Positioned as primary Vcore supplier for Nvidia, with higher content expected for Rubin Ultra [1].

Intel (INTC):

• Price target maintained at $155 [2].
• Anticipates strong server CPU performance driven by agentic AI demand [2].
• Foundry expansion with commitments from Broadcom, Alphabet, Apple, AMD, Microsoft, and Nvidia [2].

Both companies are seen benefiting from the ongoing AI infrastructure buildout, with KeyBanc's estimates for Q3/Q4 revenue and EPS exceeding consensus [1] [2].

Nokia (NOK) shares rallied over 2.5% pre-market after IndeRes upgraded the stock from Sell to Reduce, raising its price target to EUR 7 from EUR 6.5 [1]. The upgrade follows Nokia's Q3 earnings beat, with adjusted EPS of $0.10 vs. $0.08 consensus and revenue of $5.84B vs. $5.72B [1]. Management also guided for Q4 net sales to jump 20-24% QoQ [1].

Further boosting sentiment, Nokia and Nvidia announced a significant AI-RAN partnership, with nearly 20 global telecom operators already running or piloting the technology [1]. This strategic collaboration, combined with improved visibility into Nokia's growth trajectory in optical and IP networks, signals strong momentum for the company [1].

Global pension systems are confronting a severe demographic crisis, labeled a 'ticking time bomb' by experts [1]. Longer lifespans and dwindling birth rates are stretching retirement finances, threatening the sustainability of payouts for future generations.

Key concerns:

• Defined-Benefit Plans: Face mounting liabilities as retirees live longer.
• Defined-Contribution Plans: Members risk outliving savings, increasing pressure on investment returns.
• Demographic Shift: 43 out of 55 pension systems in the 2026 Marsh CFA Institute Global Pension Index have fertility rates below replacement levels. Life expectancy at 65 has increased by 50.9% since 1950 [1].

This structural challenge implies significant long-term pressure on government budgets, investment strategies, and intergenerational wealth transfer.

Concerns over AI capital availability are intensifying, with Meta Platforms raising its 2026 capital spending forecast to $135B-$145B and announcing new non-voting shares to facilitate fundraising [1]. CEOs from Broadcom, BlackRock, and Nvidia echo worries about capital becoming the biggest constraint on AI development [1].

This sentiment triggered a significant market reaction:

• AI-linked stocks like Nvidia (-4.4%), CoreWeave (-10.1%), and Lam Research (-11.8%) fell.
• The iShares Semiconductor ETF (SOXX) dropped 6.8%, and the Nasdaq declined 2.6% [1].

While the S&P 500 equal-weight index edged up, the cap-weighted version fell, suggesting a rotation out of large-cap tech. Treasury yields also fell, indicating market concern that tighter capital could slow the AI buildout [1]. This marks a material development in the ongoing AI funding narrative, previously highlighted by debt concerns and investor reluctance.

Brookfield Asset Management (BAM) is opening a new office in Doha, Qatar, to expand its Middle East operations, including its global credit platform Oaktree Capital Management [1]. This move builds on an existing $20 billion AI infrastructure partnership with the Qatar Investment Authority (QIA) [1]. The expansion highlights a broader trend of international investment managers deepening ties with Gulf sovereign wealth funds [1].

The Biotech sector is experiencing a significant innovation boom, with the iShares Biotechnology ETF (IBB) up 24% year-to-date through October 23, building on a 28% gain in 2025 [1]. Analysts point to a powerful innovation cycle driven by clinical trial results, M&A activity, and promising technologies like genomics, mRNA, and AI [1].

Key drivers:

• Innovation Cycle: New modalities and improved disease biology understanding are leading to novel drug development.
• FDA Approvals: 12 novel biologic drugs approved in 2025, with 66 novel drugs in the pipeline.
• AI Integration: AI and machine learning are accelerating drug discovery and development, creating predictive models previously unattainable [1].

This broad sector strength suggests continued investor interest in biotech innovation. [1]